244: What’s happened in Washington (so far) and what policy changes we’re bracing for

In the first two months of the Trump administration, the political and regulatory environment have shifted considerably. Since the inauguration, we’ve fielded dozens of questions about the slew of executive orders, cuts to research funding, HHS layoffs, tariffs, and an unstable economic outlook. All of that is coupled with the potential for major payment cuts to government-funded healthcare and rising scrutiny over public health and the healthcare industry writ large. The sheer pace of change leaves many healthcare leaders wondering where they need to focus their attention and energy. This week, we’re here to clarify some of the chaos and help leaders focus their efforts on what is most pressing and most actionable. To do that, host Rachel (Rae) Woods invites Advisory Board experts Natalie Trebes and Max Hakanson to break down the operating conditions as the second Trump term takes shape. We’re here to help: If there are specific policy areas or issues that you want to hear more about, or you are interested in talking to our research team (or getting access to our working documents), let us know by leaving us a voice message or emailing us. Links: Ep. 230: Elections results are in: What healthcare leaders need to know How could Trump’s new tariffs impact healthcare? Thousands laid off at HHS: What you need to know RFK Jr. wants to change how Medicare pays doctors Health policy roundup: The latest on measles, abortion, and gender-affirming care Health policy roundup: Trump signs executive order on price transparency Learn more about the origins of Ozempic Learn more about the Advisory Board Summit in Carlsbad, CA. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.